LCM

Lynx1 Capital Management Portfolio holdings

AUM $346M
1-Year Est. Return 2.97%
This Quarter Est. Return
1 Year Est. Return
-2.97%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$151M
AUM Growth
-$1.44M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
25
New
Increased
Reduced
Closed

Top Buys

1
+$6.74M
2
+$3.18M
3
+$2.32M
4
NEUP
Neuphoria Therapeutics
NEUP
+$2.2M
5
CCCC icon
C4 Therapeutics
CCCC
+$1.9M

Top Sells

1
+$7.06M
2
+$3.14M
3
+$3.04M
4
NGNE icon
Neurogene
NGNE
+$2.57M
5
CGEM icon
Cullinan Oncology
CGEM
+$1.24M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
1
$32.1M 21.2%
2,106,000
-75,377
2
$27.5M 18.21%
2,404,614
-265,858
3
$27.1M 17.94%
1,150,225
-2,300
4
$14.8M 9.8%
994,161
-210,889
5
$13.4M 8.85%
5,224,600
6
$11.1M 7.33%
1,103,178
+133,804
7
$6.74M 4.46%
+1,710,154
8
$3.18M 2.1%
+1,363,025
9
$2.91M 1.93%
122,198
10
$2.8M 1.85%
1,997,006
-51,730
11
$2.32M 1.53%
+235,787
12
$2.2M 1.46%
+67,959
13
$1.9M 1.25%
+1,019,230
14
$1.89M 1.25%
702,415
-54,594
15
$1.05M 0.7%
+117,788
16
$125K 0.08%
9,506
-48,861
17
$65.5K 0.04%
+9,917
18
$24.8K 0.02%
1,827
19
– –
-193,573
20
– –
-115,063
21
– –
-20,114
22
– –
-23,000
23
– –
-154,728
24
– –
-21,225
25
– –
-3,902,434